Multicenter Trial of Prednisone in Alzheimer's Disease
Launched by NATIONAL INSTITUTE ON AGING (NIA) · Oct 29, 1999
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with Alzheimer's disease who are in stable medical condition
- Exclusion Criteria:
- • Patients with diabetes or severe osteoporosis
About National Institute On Aging (Nia)
The National Institute on Aging (NIA) is a prominent research organization within the National Institutes of Health (NIH) dedicated to advancing our understanding of aging and age-related diseases. Through a robust portfolio of clinical trials, the NIA focuses on innovative research that aims to enhance the health and well-being of older adults. By fostering collaboration among scientists, healthcare professionals, and communities, the NIA seeks to translate research findings into practical solutions that improve the quality of life for aging populations. Their commitment to rigorous scientific inquiry and public health underscores their role as a leader in geriatric research and the pursuit of effective interventions for age-associated conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Los Angeles, California, United States
Tampa, Florida, United States
Jacksonville, Florida, United States
Kansas City, Kansas, United States
Minneapolis, Minnesota, United States
St. Louis, Missouri, United States
New York, New York, United States
Pittsburgh, Pennsylvania, United States
Nashville, Tennessee, United States
Dallas, Texas, United States
Birmingham, Alabama, United States
Rochester, New York, United States
San Diego, California, United States
New York, New York, United States
White Plains, New York, United States
Indianapolis, Indiana, United States
New York, New York, United States
Miami, Florida, United States
Patients applied
Trial Officials
Leon Thal, MD.
Principal Investigator
University of California, San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials